TRCT
PMI

Tower Research Capital (TRC)’s Picard Medical PMI Stock Holding History

Tower Research Capital (TRC)’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.02K Buy
2,909
+2,794
+2,430% +$4.05K ﹤0.01% 4377
2025
Q4 		$201 Buy
+115
New +$541 ﹤0.01% 4994

Other funds holding PMI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tower Research Capital (TRC)'s PMI Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Picard Medical (PMI) stake by 2,430% in Q1 2026, buying an estimated $4.05K and bringing the position to 2,909 shares worth $3.02K. The position accounts for ﹤0.01% of the portfolio, ranked #4377.

Tower Research Capital (TRC) first reported a position in PMI in Q4 2025 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold PMI as of Q1 2026.

  • Tower Research Capital (TRC) held 2,909 shares of Picard Medical worth $3.02K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,794 Picard Medical shares in Q1 2026, an estimated $4.05K.
  • Picard Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4377 holding.
  • Tower Research Capital (TRC) first reported a position in Picard Medical in Q4 2025 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Picard Medical as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.